Q1 2026 earnings call recap: revenue, EPS, ARR, AI innovation, ShareFile integration, churn risks, and 2026 guidance—read now.
Explore the significance of drug–target interactions in drug discovery and the challenges of fragmented data in research.
The more of a business person you can be, the more of an effective in-house lawyer you will be’: Quint CLO Sheraz Afzal ...
For months, lone vibe coder Rafael Concepcion has obsessively built tools to counter the federal immigration ...
The Arena Group trades at a steep discount despite improved profitability and a drastically reduced cost structure post-2023 ...
A wholly foreign‑owned enterprise (WFOE) remains the preferred entry structure for many foreign investors in China in 2026.
With the Azure Copilot handling infrastructure, the modernization tools in GitHub Copilot’s agents can help work through the ...
ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, ...
As the United States and its competitors race to field AI capabilities, the decisive edge will belong to whoever can deploy ...
As Grab’s mobility, delivery and fintech engines scale, we see a growing profit pool and a valuation still anchored in its ...
Today's nearly $70 billion U.S. biofuels economy is powered by two technology toolboxes. Biochemical technologies—used to produce around 17 billion gallons of ethanol annually—leverage microorganisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results